Saracatinib (AZD0530)
AZD0530 is a dually active inhibitor of c-Src and Bcr-ABL, on bone resorption. AZD0530 inhibited tumor growth in a manner independent of dose and inhibited phosphorylation of focal adhesion kinase (FAK) and paxillin in a dose-dependent manner in a Calu-6 Xenograft model.
Product Specifications
Shipping Conditions
RT
Storage Conditions
-20°C
Shelf Life
24months
More Discoveries
Explore Other Products
Browse additional items from our catalog